Physician profile
David A Nesbitt
NPI 1881791390
$15,133.34
in general payments reported to CMS, 2019-2025
18 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $14K · 2021: $425 · 2022: $131 · 2023: $80.07 · 2024: $152 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,056.26 | 2020-2021 | |
| Medtronic, INC. | $167.56 | 2021-2025 | Interstim |
| Takeda Pharmaceuticals U.S.A., INC. | $144.51 | 2019-2025 | Gattex |
| Ferring Pharmaceuticals INC. | $141.96 | 2019-2025 | Rebyota, Clenpiq |
| Braintree Laboratories, INC. | $99.38 | 2019-2023 | Sutab, Suflave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.72 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $75.67 | 2019-2025 | Bridion |
| Ethicon US, LLC | $50.51 | 2024-2025 | Ethicon, Echelon Flex, Harmonic |
| Acelrx Pharmaceuticals, INC. | $46.94 | 2021 | |
| Coloplast Corp | $46.00 | 2023 | Coloplast Tfl Drive |
| Boston Scientific Corporation | $34.57 | 2025 | Wavewriter Alpha Prime 16, Axonics |
| Axonics, INC. | $34.07 | 2023-2024 | Bulkamid, Axonics |
| Abbvie INC. | $31.93 | 2019-2020 | |
| Biom'Up France Sas | $29.62 | 2021 | |
| Davol INC. | $23.16 | 2024 | Phasix Mesh |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $19.76 | 2025 | |
| Janssen Biotech, INC. | $18.65 | 2021 | |
| Smith+Nephew, INC. | $18.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nesbitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.